These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 2565588)

  • 1. An alpha 2 adrenoceptor antagonist, Org 3770, enhances nocturnal melatonin secretion in man.
    Palazidou E; Papadopoulos A; Sitsen A; Stahl S; Checkley S
    Psychopharmacology (Berl); 1989; 97(1):115-7. PubMed ID: 2565588
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of long-term treatment with the alpha 2-adrenoceptor antagonist mirtazapine on 5-HT neurotransmission.
    Haddjeri N; Blier P; de Montigny C
    Naunyn Schmiedebergs Arch Pharmacol; 1997 Jan; 355(1):20-9. PubMed ID: 9007838
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The alpha 2-adrenoceptor antagonist Org 3770 enhances serotonin transmission in vivo.
    De Boer T; Nefkens F; Van Helvoirt A
    Eur J Pharmacol; 1994 Feb; 253(1-2):R5-6. PubMed ID: 7912194
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differences in modulation of noradrenergic and serotonergic transmission by the alpha-2 adrenoceptor antagonists, mirtazapine, mianserin and idazoxan.
    de Boer TH; Nefkens F; van Helvoirt A; van Delft AM
    J Pharmacol Exp Ther; 1996 May; 277(2):852-60. PubMed ID: 8627567
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evidence for a functional role of alpha-1 adrenoceptors in the regulation of melatonin secretion in man.
    Palazidou E; Franey C; Arendt J; Stahl S; Checkley S
    Psychoneuroendocrinology; 1989; 14(1-2):131-5. PubMed ID: 2543998
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of the alpha-2 adrenoceptor antagonist mirtazapine on the 5-hydroxytryptamine system in the rat brain.
    Haddjeri N; Blier P; de Montigny C
    J Pharmacol Exp Ther; 1996 May; 277(2):861-71. PubMed ID: 8627568
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mirtazapine decreases stimulatory effects of reboxetine on cortisol, adrenocorticotropin and prolactin secretion in healthy male subjects.
    Schüle C; Baghai T; Laakmann G
    Neuroendocrinology; 2004 Jan; 79(1):54-62. PubMed ID: 14755134
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interaction of the antidepressant mirtazapine with alpha2-adrenoceptors modulating the release of 5-HT in different rat brain regions in vivo.
    Bengtsson HJ; Kele J; Johansson J; Hjorth S
    Naunyn Schmiedebergs Arch Pharmacol; 2000 Nov; 362(4-5):406-12. PubMed ID: 11111835
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Anxiolytic-like profile of mirtazapine in rat conditioned fear stress model: Functional significance of 5-hydroxytryptamine 1A receptor and alpha1-adrenergic receptor.
    Kakui N; Yokoyama F; Yamauchi M; Kitamura K; Imanishi T; Inoue T; Koyama T
    Pharmacol Biochem Behav; 2009 May; 92(3):393-8. PubMed ID: 19167420
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Changes of sleep architecture, spectral composition of sleep EEG, the nocturnal secretion of cortisol, ACTH, GH, prolactin, melatonin, ghrelin, and leptin, and the DEX-CRH test in depressed patients during treatment with mirtazapine.
    Schmid DA; Wichniak A; Uhr M; Ising M; Brunner H; Held K; Weikel JC; Sonntag A; Steiger A
    Neuropsychopharmacology; 2006 Apr; 31(4):832-44. PubMed ID: 16237393
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of idazoxan on evening melatonin plasma concentrations in healthy volunteers.
    Grasby PM; Begg EJ; Gartside SE; Cowen PJ
    Biol Psychiatry; 1989 Aug; 26(4):412-6. PubMed ID: 2569897
    [No Abstract]   [Full Text] [Related]  

  • 12. Studies on the pharmacokinetics and pharmacodynamics of mirtazapine in healthy young cats.
    Quimby JM; Gustafson DL; Samber BJ; Lunn KF
    J Vet Pharmacol Ther; 2011 Aug; 34(4):388-96. PubMed ID: 20969604
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Alpha 2-autoreceptors and alpha 2-heteroreceptors modulating tyrosine and tryptophan hydroxylase activity in the rat brain in vivo: an investigation into the alpha 2-adrenoceptor subtypes.
    Esteban S; Lladó J; García-Sevilla JA
    Naunyn Schmiedebergs Arch Pharmacol; 1996 Mar; 353(4):391-9. PubMed ID: 8935705
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of mirtazapine on rat bone tissue after orchidectomy.
    Fekete S; Simko J; Mzik M; Karesova I; Zivna H; Pavlíková L; Palicka V
    Pharmacology; 2015; 95(3-4):166-72. PubMed ID: 25871861
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparative Evaluation of Partial α2 -Adrenoceptor Agonist and Pure α2 -Adrenoceptor Antagonist on the Behavioural Symptoms of Withdrawal after Chronic Alcohol Administration in Mice.
    Arora S; Vohora D
    Basic Clin Pharmacol Toxicol; 2016 Aug; 119(2):202-9. PubMed ID: 26867012
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Influence of mirtazapine on salivary cortisol in depressed patients.
    Laakmann G; Hennig J; Baghai T; Schüle C
    Neuropsychobiology; 2003; 47(1):31-6. PubMed ID: 12606843
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Influence of sex and CYP2D6 genotype on mirtazapine disposition, evaluated in Spanish healthy volunteers.
    Borobia AM; Novalbos J; Guerra-López P; López-Rodríguez R; Tabares B; Rodríguez V; Abad-Santos F; Carcas AJ
    Pharmacol Res; 2009 Jun; 59(6):393-8. PubMed ID: 19429471
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Alpha 2-adrenoceptor antagonists as antidepressants: the search for selectivity.
    Pinder RM; Sitsen JM
    Psychopharmacol Ser; 1987; 3():107-12. PubMed ID: 2881289
    [No Abstract]   [Full Text] [Related]  

  • 19. Low doses of alpha 2-adrenoceptor antagonists augment spinal morphine analgesia and inhibit development of acute and chronic tolerance.
    Milne B; Sutak M; Cahill CM; Jhamandas K
    Br J Pharmacol; 2008 Dec; 155(8):1264-78. PubMed ID: 18806811
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of repeated treatment with mirtazapine on the central alpha1-adrenergic receptors.
    Rogoz Z; Wrobel A; Dlaboga D; Maj J; Dziedzicka-Wasylewska M
    J Physiol Pharmacol; 2002 Mar; 53(1):105-16. PubMed ID: 11939713
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.